Literature DB >> 1564026

The Mania Rating Scale: can it be used in children? A preliminary report.

M A Fristad1, E B Weller, R A Weller.   

Abstract

The Mania Rating Scale (MRS) was evaluated for use in prepubertal children. Eleven manic and 11 matched controls with attention-deficit hyperactivity disorder were examined. MRS scores were significantly higher in manic versus ADHD children (p less than 0.0001), while scores on hyperactivity rating scales (Conners-Parent and Teacher Forms) did not differ between groups. Most individual MRS item scores differed significantly between groups (p less than 0.05). MRS scores correlated significantly with severity of mania (Clinical Global Impression--Mania, r = 0.84; p less than 0.0001). Age, race, and sex were not correlated with MRS scores. The MRS may be useful in differentiating mania from ADHD and determining the severity of mania in prepubertal children.

Entities:  

Mesh:

Year:  1992        PMID: 1564026     DOI: 10.1097/00004583-199203000-00011

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  38 in total

1.  Validity of the Expressed Emotion Adjective Checklist (EEAC) in Caregivers of Children with Mood Disorders.

Authors:  Nicole M Klaus; Guillermo Perez Algorta; Andrea S Young; Mary A Fristad
Journal:  Couple Family Psychol       Date:  2015-03

2.  Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.

Authors:  Robert L Findling; Eric A Youngstrom; Mary A Fristad; Boris Birmaher; Robert A Kowatch; L Eugene Arnold; Thomas W Frazier; David Axelson; Neal Ryan; Christine A Demeter; Mary Kay Gill; Benjamin Fields; Judith Depew; Shawn M Kennedy; Linda Marsh; Brieana M Rowles; Sarah McCue Horwitz
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

3.  Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.

Authors:  L Eugene Arnold; Andrea S Young; Martha A Belury; Rachel M Cole; Barbara Gracious; Adina M Seidenfeld; Hannah Wolfson; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-03       Impact factor: 2.576

4.  Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD.

Authors:  L Eugene Arnold; Stephen J Ganocy; Katherine Mount; Eric A Youngstrom; Thomas Frazier; Mary Fristad; Sarah M Horwitz; Boris Birmaher; Robert Findling; Robert A Kowatch; Christine Demeter; David Axelson; Mary Kay Gill; Linda Marsh
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-04-30       Impact factor: 8.829

5.  A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation.

Authors:  James G Waxmonsky; Daniel A Waschbusch; Peter Belin; Tan Li; Lysett Babocsai; Hugh Humphery; Meaghan E Pariseau; Dara E Babinski; Martin T Hoffman; Jenifer L Haak; Jessica R Mazzant; Gregory A Fabiano; Jeremy W Pettit; Negar Fallahazad; William E Pelham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-12-28       Impact factor: 8.829

6.  Sleep-Wake Patterns of Adolescents with Borderline Personality Disorder and Bipolar Disorder.

Authors:  Christophe Huỳnh; Jean-Marc Guilé; Jean-Jacques Breton; Roger Godbout
Journal:  Child Psychiatry Hum Dev       Date:  2016-04

7.  Anxiety in children with mood disorders: a treatment help or hindrance?

Authors:  Colleen M Cummings; Mary A Fristad
Journal:  J Abnorm Child Psychol       Date:  2012-04

8.  Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.

Authors:  Robert A Kowatch; Russell E Scheffer; Erin Monroe; Sergio Delgado; Mekibib Altaye; Denise Lagory
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

9.  Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms.

Authors:  Danella Hafeman; David Axelson; Christine Demeter; Robert L Findling; Mary A Fristad; Robert A Kowatch; Eric A Youngstrom; Sarah McCue Horwitz; L Eugene Arnold; Thomas W Frazier; Neal Ryan; Mary Kay Gill; Jessica C Hauser-Harrington; Judith Depew; Brieana M Rowles; Boris Birmaher
Journal:  Bipolar Disord       Date:  2013-03-25       Impact factor: 6.744

10.  Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.

Authors:  Eric Youngstrom; Joan Zhao; Raymond Mankoski; Robert A Forbes; Ronald M Marcus; William Carson; Robert McQuade; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.